HC Wainwright & Co. analyst Robert Burns maintains ADC Therapeutics (NYSE:ADCT) with a Buy and raises the price target from $20 to $21.
Marcus & Millichap Q2 EPS $1.04 Beats $0.84 Estimate, Sales $395.96M Beat $335.30M Estimate
Marcus & Millichap (NYSE:MMI) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.84 by 23.81 percent. This is a 33.33 percent increase over earnings of $0.78 per share from the
